100 Reasons to Invest In Cellmid, page-72

fundamentals are very important obviously but what drives the share price just as much if not more especially with small caps is sentiment do you think a2m , 1pg , ahf etc are doing as great fundamentally as there share price is performing ? , not even close , but sentiment , excitement , buzz is high
When news is updated about asian expansion , more news about introduction of products into the united states and midkine updates ( clinical trials ) that is what will make a huge impact on the sp .

I have invested alot in the united states with small caps biotechs , have done well mostly , many of them do not have very good fundamentals , but the sentiment was strong ( pre clinical and phase 1 ) trials are the easiest to make look better than they are and these kind of annoucements will make the largest impact on the sp in the upwards direction . So far pre clinical studies have shown no toxicity even in larger doses which is huge . When you get deeper into Phase 2a , 2b , efficacy , and larger trial participants thats when it gets much harder and much more risky in all ways , as many unfortunately do not go great or have set backs . The stage where Cellmid is at the least risky and by far the easiest part of the whole process that is why I confident when we hear news it should be good .